Target EphA2 receptor for cancer therapy

被引：0
作者：
Wang, Si [1 ]
Stebbins, John [1 ]
Noberini, Roberta [1 ]
Zhang, Ziming [1 ]
Pellecchia, Maurizio [1 ]
Pasquale, Elena [1 ]
Kitada, Shinichi [1 ]
Fisher, Paul [1 ]
机构：
[1] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92130 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
342-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Negative regulation of EphA2 receptor by Cbl
    Wang, YJ
    Ota, S
    Kataoka, H
    Kanamori, M
    Li, ZY
    Band, H
    Tanaka, M
    Sugimura, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) : 214 - 220
  • [22] Roles of EphA2 receptor signaling in prostate cancer development and progression
    Lingerak, Ryan
    Petty, Aaron
    Guo, Hong
    Lin, Hebei
    Shi, Xiaojun
    Kim, Soyeon
    Wang, Bingcheng
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Silencing Epha2 Receptor Increases Sensitivity To Chemotherapy In Lung Cancer
    Nasreen, N.
    Lee, H.
    Kaye, F.
    Jantz, M.
    Mohammed, K. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)
    Foveau, Benedicte
    Boulay, Gaylor
    Pinte, Sebastien
    Van Rechem, Capucine
    Rood, Brian R.
    Leprince, Dominique
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) : 5366 - 5378
  • [25] EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease
    Vaught, David B.
    Merkel, Alyssa R.
    Lynch, Conor C.
    Edwards, James
    Tantawy, Mohammed Noor
    Hilliard, Timothy
    Wang, Shan
    Peterson, Todd
    Johnson, Rachelle W.
    Sterling, Julie A.
    Brantley-Sieders, Dana
    JBMR PLUS, 2021, 5 (04)
  • [26] EphA2 as a new target for breast cancer and its potential clinical application
    Zhou, Lingzhi
    Lu, Xuejing
    Zhang, Bensi
    Shi, Yaqi
    Li, Zhuang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (04): : 484 - 492
  • [27] Molecular predictors of response to EphA2 targeted therapy in uterine cancer
    Sood, A. K.
    Huang, J.
    Hu, W.
    Previs, R. A.
    Dalton, H. J.
    Hansen, J. M.
    Sun, Y.
    Nick, A. M.
    Broaddus, R.
    Coleman, R. L.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 59 - 59
  • [28] Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
    Zhuang, Guanglei
    Brantley-Sieders, Dana M.
    Vaught, David
    Yu, Jian
    Xie, Lu
    Wells, Sam
    Jackson, Dowdy
    Muraoka-Cook, Rebecca
    Arteaga, Carlos
    Chen, Jin
    CANCER RESEARCH, 2010, 70 (01) : 299 - 308
  • [29] EPHA2, a promising therapeutic target for hepatocellular carcinoma
    Wang, Hao
    Qiu, Wei
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)
  • [30] EphA2 receptor represents a new marker and therapeutic target in glioblastoma multiforme (GBM)
    Debinski, W
    Floyd, JF
    Harbaugh, DI
    Gibo, DM
    NEURO-ONCOLOGY, 2004, 6 (04) : 336 - 337
12345